Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis

Trial Profile

Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 24 May 2018

At a glance

  • Drugs Hypochlorous acid (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Sponsors Realm Therapeutics
  • Most Recent Events

    • 24 May 2018 Status changed from recruiting to active, no longer recruiting, according to a Realm Therapeutics media release.
    • 15 Feb 2018 According to Realm Therapeutics media release, the study is progressing as planned and top-line results are expected by the end of Q3.
    • 19 Dec 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top